Literature DB >> 8283528

Vascular abnormalities in Peyronie's disease: the role of color Doppler sonography.

F Montorsi1, G Guazzoni, F Bergamaschi, P Consonni, P Rigatti, G Pizzini, A Miani.   

Abstract

We attempted to clarify the role of color Doppler sonography in assessing the vascular function of untreated Peyronie's disease. A total of 50 patients with a mean 20-month history of penile curvature underwent color Doppler sonography with the penis in the flaccid state and after intracavernous injection of 20 micrograms. prostaglandin E1. Of the patients 41 (82%) complained of various degrees of erectile dysfunction, while 9 (18%) reported sustained rigid erections. Pathological peak systolic flow velocities (less than 30 cm. per second) of the cavernous arteries were found bilaterally in 10 patients (20%) and unilaterally in 10 (20%). Peak systolic flow velocity correlated positively with cavernous artery flow volume and with acceleration. Cavernous artery end diastolic velocity and resistance index, measured 15 and 30 minutes after vasoactive injection and genital manipulation, were indicative of corporeal veno-occlusive dysfunction (greater than 10 and less than 0.75 cm. per second, respectively) in 32 patients (65%). Of these patients, 11 (22%) had mixed arteriovenous dysfunction and 9 (18%) had normal cavernous artery flow velocities. Flow along the cavernous arteries is sometimes altered in cases of Peyronie's disease while corporeal veno-occlusive dysfunction seems to be the main hemodynamic abnormality. Color Doppler sonography should be considered as the initial step in the diagnostic evaluation of patients with Peyronie's disease who may be eligible for surgical treatment.

Entities:  

Mesh:

Year:  1994        PMID: 8283528     DOI: 10.1016/s0022-5347(17)34952-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

1.  Techniques of corporoplasty for penile curvature: review of 18 patients.

Authors:  E Batislam; L Peşkircioğlu; C Germiyanoğlu; D Erol
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

2.  Patient-partner satisfaction with intracavernous medication supported with oral agents in selected cases of Peyronie's disease. A ten-month follow-up study.

Authors:  M Culha; N Mutlu; O Acar; B Alici
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

Review 3.  Erectile dysfunction: symptom or disease?

Authors:  C Foresta; N Caretta; A Aversa; C Bettocchi; G Corona; S Mariani; M Rossato
Journal:  J Endocrinol Invest       Date:  2004-01       Impact factor: 4.256

4.  The direction and severity of penile curvature does not have an impact on concomitant vasculogenic erectile dysfunction in patients with Peyronie's disease.

Authors:  E C Serefoglu; L Trost; S C Sikka; W J G Hellstrom
Journal:  Int J Impot Res       Date:  2014-07-17       Impact factor: 2.896

5.  Penile vascular indices in surgically treated and conservatively treated penile fracture: does conventional immediate repair matter?

Authors:  Mohammad Reza Safarinejad; Mohammad Hossein Lashkari; Alireza Babaei; Farid Dadkhah; Ali Asghar Kolahi
Journal:  Int Urol Nephrol       Date:  2012-09-16       Impact factor: 2.370

Review 6.  Investigation of erectile dysfunction.

Authors:  D V Patel; J Halls; U Patel
Journal:  Br J Radiol       Date:  2012-11       Impact factor: 3.039

Review 7.  Surgery for Peyronie's disease.

Authors:  Laurence A Levine; Stephen M Larsen
Journal:  Asian J Androl       Date:  2012-11-26       Impact factor: 3.285

8.  US Imaging in Peyronie's Disease.

Authors:  Kiriaki Kalokairinou; Charalampos Konstantinidis; Marilena Domazou; Theodoros Kalogeropoulos; Prodromos Kosmidis; Aristomenis Gekas
Journal:  J Clin Imaging Sci       Date:  2012-10-31

Review 9.  Epidemiology regarding penile prosthetic surgery.

Authors:  Jose A Saavedra-Belaunde; Jonathan Clavell-Hernandez; Run Wang
Journal:  Asian J Androl       Date:  2020 Jan-Feb       Impact factor: 3.285

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.